NL
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Case report : From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing study | Frontiers in oncology | 2024 | 40 | 27 | |||
Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | 2024 | 20 | 33 | |||
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity | BMJ open | 2023 | 379 | 54 | |||
L'agranulocytose liée à la chimiothérapie comme facteur prédictif des mutations germinales BRCA1 chez les patientes atteintes d'un cancer du sein | 2023 | 172 | 67 | ||||
Efficacy of immune checkpoint blockade and biomarkers of response in lymphoma: a narrative review | Biomedicines | 2023 | 59 | 56 | |||
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives | Biomedicines | 2022 | 176 | 103 | |||
Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels | Revue médicale suisse | 2022 | 110 | 56 | |||
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes | Scientific Reports | 2020 | 289 | 286 |